Research programme: recombinant human heparanase skin therapeutics - Insight
Alternative Names: Rh Heparanase - InSightLatest Information Update: 16 Jul 2016
At a glance
- Originator InSight Biopharmaceuticals
- Class Glycoside hydrolases
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Wounds in Israel
- 06 Jun 2005 Preclinical trials in Wounds in Israel (unspecified route)